Skip to content

The effect of Jinlida granule on glycemic excursion and metabonomics in type 2 diabetic patients

The effect of Jinlida granule on glycemic excursion and metabonomics in type 2 diabetic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009296
Enrollment
Unknown
Registered
2016-09-29
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

metformin group:metformin 0.5 tid
Jinlida group:Jinlida 1 packet tid

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. medication-naive type 2 diabetes with newly-onset; 2. Aged 30-70 years old, man or woman; 3. BMI=18.5kg/m2; 4. 7%=HbA1c=10.0%; 5. FPG=13mmol/L, 2h-PG=18mmol/L; 6. with informed consent.

Exclusion criteria

Exclusion criteria: 1. type 1 diabetes, gestational diabetes and special type of diabetes; 2. with acute complications including ketoacidosis, lactic acidosis, hyperosmolar coma and infection in recent 1 month; 3. with severe heart disease, or with myocardial infarction, stroke, transient ischemic attacks, and peripheral arterial disease; 4. women with pregnancy, lactation; 5. with renal or hepatic dysfunction; 6. systolic pressure >180mmHg and/or diastolic pressure>110mmHg; 7. with acute or chronic pancreatitis, or with severe cardiovascular disease, malignancy, and severe mental disease; 8. alcohol, drug addiction; 9. FPG>13mmol/L and/or 2h-PG>18mmol/L; 10. with allergic reaction; 11. with hyperthyroidism or hypothyroidism; 12. with medication influencing on glucose metabolism including glucocorticoid, thyroxine, thiazide diuretics.

Design outcomes

Primary

MeasureTime frame
HbA1c;

Secondary

MeasureTime frame
lipid level;glycemic excursion;classificationof traditional medical symptom;HOMA-IR;urinary albumin excretion;

Countries

China

Contacts

Public ContactPan Jiemin

Shanghai Sixth People's Hospital

lilypjm@hotmail.com+86 13917159314

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026